March 14, 2026 10:15 ET | Source: Senseonics Holdings, Inc. New data shows positive real-world impact of the world’s first…
SAN CARLOS, Calif., March 14, 2026 (GLOBE NEWSWIRE) -- Biomea Fusion, Inc. (“Biomea,” “Biomea Fusion,” or the “Company”) (Nasdaq: BMEA),…
Ann Arbor, MI, March 13, 2026 (GLOBE NEWSWIRE) -- Disclaimer: This article is for informational and educational purposes only and…
JENA, Germany, March 13, 2026 (GLOBE NEWSWIRE) -- InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics by targeting…
Lead investor confirmed his intention to maintain his current shareholdings.Company does not anticipate using more than 1% of our authorized…
Cosentyx is the only IL-17A inhibitor approved for this population, and the first differentiated mechanism in nearly a decade1-3 HS often emerges around…
March 13, 2026 15:00 ET | Source: Microvast Holdings, Inc. STAFFORD, Texas, March 13, 2026 (GLOBE NEWSWIRE) -- Microvast Holdings,…
Brussels, March 13, 2026 (GLOBE NEWSWIRE) -- The Cloud Signature Consortium (CSC) announced the full programme of the Trust Without…
SAN FRANCISCO, March 13, 2026 (GLOBE NEWSWIRE) -- In response to the growing complexity of AI-driven decision-making across industries, technology…
March 12, 2026 21:03 ET | Source: Eupraxia Pharmaceuticals Inc. VICTORIA, British Columbia, March 12, 2026 (GLOBE NEWSWIRE) -- Eupraxia…